
Pentorom 40mg Injection
Marketer
Alleviate Pharmaceuticals Pvt. Ltd.
Salt Composition
Pantoprazole (40mg)
Overview Pentorom 40mg Injection
Gastric acid secretion is reduced by the intravenous administration of 40mg Axid Injection, indicated for various gastrointestinal disorders including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It facilitates symptom relief and promotes healing. Prophylactically, it's used to prevent stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injectable medication is administered solely by a healthcare professional, reserved for patients where parenteral therapy is deemed clinically preferable to oral forms. Dosage is individualized, adjusted based on condition and response. Treatment duration, determined by your physician, should be adhered to even with rapid symptom resolution. Lifestyle modifications, such as frequent, smaller meals and avoidance of caffeine, spicy, and fatty foods, can enhance treatment efficacy. Commonly reported side effects, usually mild, encompass nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome effects necessitate medical consultation. Prolonged use, especially exceeding one year, may elevate bone fracture risk, particularly at higher doses. Discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your doctor. Axid Injection is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating women should seek medical guidance prior to use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if experiencing dizziness or somnolence.
Uses of Pentorom 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pentorom 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pentorom 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pentorom 40mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Pentorom 40mg Injection works:
Axipent 40mg Injection, a proton pump inhibitor, decreases gastric acid production, thus alleviating symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pentorom 40mg Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Pentorom 40mg Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Pentorom 40mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pentorom 40mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The administration of Pentorom 40mg Injection is considered safe for individuals with renal impairment. No modification of the Pentorom 40mg Injection dosage is necessary.
LiverCAUTION
Administering Pentorom 40mg Injection requires careful consideration in individuals exhibiting severe hepatic impairment. Dosage modification of Pentorom 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Pentorom 40mg Injection :
Omit a dose of Pentorom 40mg Injection? Seek medical advice immediately.
Facts to Know About Pentorom 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfoxide analog |
| Potential for Dependence | None. |
| Treatment Category | Gastrointestinal system |
| Mechanism of Action | Gastric acid secretion suppressants |
